Please assess the completion status of the following clinical trial:

Trial Title: Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* scheduled for major vascular surgery~* can sign informed consent before surgery~* documented CAD or risk factors for CAD~Exclusion Criteria:~* Preoperative treatment with beta-adrenergic agonists or glucocorticoids,~* electrocardiographic (ECG) abnormalities like nonsinus rhythm, second- or third degree heart block, or left bundle branch block,~* cardiac pacemaker dependency,~* symptomatic mitral or aortic valvular disease,~* a history of asthma, bronchospasm, or severe chronic obstructive pulmonary disease necessitating bronchodilator therapy,~* severe liver dysfunction~* known allergies against the study drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).